Whether extended pelvic lymph node dissection should be performed in prostate cancer: The present evidence from a systematic review and meta‐analysis
Precision Medical Sciences · 2020
DOI: 10.1002/prm2.12005 ↗Abstract
Abstract Purpose To compare non‐extended pelvic lymph node dissection (nePLND) with extended pelvic lymph node dissection (ePLND) in outcomes and complications of patients with prostate cancer (PCa). Methods A comprehensive search of the PubMed, EMBASE, and Web of Science was performed. We extracted the first author, year of publication, basic characteristics of patients, method of radical prostatectomy (RP), extent of PLND, number of lymph node yields (LNY), and percentage of LN metastasis. Besides, information about inpatients outcomes and complications were also collected. The modified Newcastle‐Ottawa scale was compiled to assess the level of evidence of all controlled studies. Next, we used odds ratio (OR) with corresponding 95% confidence interval (CI) to evaluate the difference between nePLND and ePLND in meta‐analysis, and a P value of
EUVIMED